Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-04

FDA Approved: LEVETIRACETAM — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved a generic injectable form of levetiracetam in saline (LEVETIRACETAM IN SODIUM CHLORIDE) under an Original Application by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM IN SODIUM CHLORIDE)